The FDA wants to "Bring MedTech Manufacturing Home" – and it's well on its way to fulfilling that goal with its burgeoning Case for Quality Voluntary Improvement Program for measuring manufacturing maturity and quality. But the agency – which has already received $6m from Congress for its America-centric initiative – is working on other programs that it hopes will spur medical device innovation and production in the US.
The Food and Drug Administration wants to spur medical device innovation and production in the US with its new "Bring MedTech Manufacturing Home" initiative – and the agency already has a leg up on that goal with its ongoing program that measures device-makers' manufacturing maturity and quality.
The FDA received $6m in funding in fiscal year 2019 for Bring MedTech Manufacturing Home, a program the agency says...